Property	Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes

Deborah J. Wexler MD, MSc Associate Editor

Kathleen M. Dungan MD, MPH Advisory Board

Silvio E. Inzucchi MD Editor-in-Chief

See All Experts

featured

Published in Diabetes

Journal Scan / Research · April 02, 2020

Fast-Acting Insulin Aspart + Insulin Degludec Is Safe and Effective in Adults With T2D

Diabetes Care

Save Recommend

Sign in to PracticeUpdate

Only registered members have full access to PracticeUpdate content.

Not a member?

Join for free

Disclosure statements are available on the authors' profiles:

Chantal Mathieu MD, PhD

Diabetes Care

A Randomized Trial Evaluating the Efficacy and Safety of Fast-Acting Insulin Aspart Compared With Insulin Aspart, Both in Combination With Insulin Degludec With or Without Metformin, in Adults With Type 2 Diabetes (Onset 9)

Diabetes Care 2020 Mar 24;[EPub Ahead of Print], WS Lane, E Favaro, N Rathor, HC Jang, MIS Kjærsgaard, A Oviedo, L Rose, P Senior, G Sesti, A Soto Gonzalez, E Franek

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Fast-Acting Insulin Aspart + Insulin Degludec Is Safe and Effective in Adults With T2D

Additional Info

A Randomized Trial Evaluating the Efficacy and Safety of Fast-Acting Insulin Aspart Compared With Insulin Aspart, Both in Combination With Insulin Degludec With or Without Metformin, in Adults With Type 2 Diabetes (Onset 9)

Further Reading

Real-World Effectiveness of Oral Semaglutide in Adults and Older Individuals With Type 2 Diabetes

Effect of Combined Use of SGLT2 Inhibitors and Pioglitazone on the Risk of MASH in Individuals With Type 2 Diabetes

Trends in the Incidence of Young Adult–Onset Diabetes by Diabetes Type

Implications of Continuous Ketone Monitoring in Clinical Practice

Characterizing the Effects of Using GLP-1 Receptor–Based Agonists on Body Composition

The SEAD Program Improved Clinical Outcomes in Underserved Young Adults With Type 1 Diabetes

Predicting Hypoglycemia and Hyperglycemia Risks During and After Physical Activity in Adolescents With Type 1 Diabetes

Family History of Diabetes and Clinical Characteristics in Children at the Diagnosis of Type 1 Diabetes

Effect of Sarcopenic Obesity on the Progression of Glycaemic Status in Middle-Aged and Older Adults Without Diabetes

Association of Early Post-Transplantation Hyperglycaemia and Diabetes Mellitus on Outcomes Following Heart Transplantation

Associations of Diabetes and Prediabetes With Mortality and Life Expectancy in Chinese Individuals

Recently Updated